Literature DB >> 27282611

Association of TNFα-308, IFNγ+874, and IL10-1082 gene polymorphisms and the risk of non-small cell lung cancer in the population of the South Indian state of Telangana.

Vidyullatha Peddireddy1,2, Siva Prasad Badabagni3, Shehnaz Sulthana4, Venkata Karunakar Kolla3, Sandhya Devi Gundimeda5, Hemaprasad Mundluru3.   

Abstract

BACKGROUND: Cytokine-mediated inflammation is important in the pathogenesis of non-small cell lung cancer (NSCLC). Genetic polymorphisms in cytokine genes and their association with lung cancer in the Indian population have not been reported.
METHODS: For the first time, we analyzed genetic polymorphisms of TNFα -308, IFNγ +874, and IL10 -1082 genes in 246 NSCLC patients and 250 healthy controls in the South Indian population from Telangana using ARMS PCR.
RESULTS: IFNγ+874 A/T and IL10-1082 G/G gene polymorphisms were found to be significantly associated with NSCLC with 1.56- and 1.68-fold disease risk, respectively. There was no association between the risk of NSCLC and TNFα-308 polymorphism. Gene polymorphisms stratified according to smoking revealed that IFNγ+874 A/T polymorphisms in smokers increased the disease risk by 2.91 fold. IL10-1082 G/G polymorphisms showed 2-fold increased risk among patients who were smokers when compared to the controls. However, there was no association between TNFα-308, IFNγ+874, and IL10-1082 gene polymorphism and the stage of the NSCLC patients. The overall risk associated with the combination of these polymorphisms indicated that the TNFα-308 G/A + IFNγ+874 A/T + IL10-1082 G/G genotype increased the risk by 1.5 fold.
CONCLUSIONS: The results of our study indicate an association between cytokine gene polymorphisms and the risk of NSCLC in an Indian population.

Entities:  

Keywords:  Gene polymorphism; Interferon-γ; Interleukin-10; Non-small cell lung cancer; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2016        PMID: 27282611     DOI: 10.1007/s10147-016-0972-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  48 in total

1.  Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers.

Authors:  H Takizawa; M Tanaka; K Takami; T Ohtoshi; K Ito; M Satoh; Y Okada; F Yamasawa; A Umeda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

2.  Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients.

Authors:  F Perini; M Morra; M Alecci; E Galloni; M Marchi; V Toso
Journal:  Neurol Sci       Date:  2001-08       Impact factor: 3.307

3.  The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.

Authors:  Kirmani Natukula; Kaiser Jamil; Usha Rani Pingali; Venkata Satya Suresh Attili; Umamaheshwar Rao Naidu Madireddy
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production.

Authors:  Nilgun Sallakci; Gayaz Akcurin; Sadi Köksoy; Firat Kardelen; Aysen Uguz; Mesut Coskun; Halil Ertug; Olcay Yegin
Journal:  J Autoimmun       Date:  2005-07-19       Impact factor: 7.094

Review 5.  Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes.

Authors:  Stacy Raviv; Keenan A Hawkins; Malcolm M DeCamp; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

6.  Different impact of IL10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma.

Authors:  Yaw-Cheng Wang; Wen-Wei Sung; Lee Wang; Ya-Wen Cheng; Chih-Yi Chen; Tzu-Chin Wu; Shwn-Huey Shieh; Huei Lee
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

7.  Intrathecal release of pro- and anti-inflammatory cytokines during stroke.

Authors:  E Tarkowski; L Rosengren; C Blomstrand; C Wikkelsö; C Jensen; S Ekholm; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

Review 8.  Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer.

Authors:  Elisa Giovannetti; Lale Erdem; Efnan Olcay; Leticia G Leon; Godefridus J Peters
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India.

Authors:  B Ganesh; Sushama L Saoba; Monika N Sarade; Suvarna V Pinjari
Journal:  Indian J Urol       Date:  2011-07

Review 10.  Inflammation and immune response in COPD: where do we stand?

Authors:  Nikoletta Rovina; Antonia Koutsoukou; Nikolaos G Koulouris
Journal:  Mediators Inflamm       Date:  2013-07-15       Impact factor: 4.711

View more
  4 in total

1.  Higher prevalence of the TNF-α G-308A heterozygous genotype in a South Indian population.

Authors:  Aditya K Panda; Harishankar Mahto
Journal:  Int J Clin Oncol       Date:  2017-03-22       Impact factor: 3.402

2.  IL-10 -1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis.

Authors:  Liang Liu; Feng Zheng
Journal:  Onco Targets Ther       Date:  2016-10-07       Impact factor: 4.147

3.  Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis.

Authors:  Ping Wang; Junling An; Yanfeng Zhu; Xuedong Wan; Hongzhen Zhang; Shoumin Xi; Sanqiang Li
Journal:  Oncotarget       Date:  2017-05-26

4.  Association of Promoter Region Polymorphisms of IL-10 Gene with Susceptibility to Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Jamal Jafari-Nedooshan; Mansour Moghimi; Mohammad Zare; Naeimeh Heiranizadeh; Majid Morovati-Sharifabad; Mohamad Javad Akbarian-Bafghi; Mohammad Hossein Jarahzadeh; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.